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INTRODUCTION 
 
 In Earlier times, starvation consigned languishing bodies to death, now on the 
other hand prosperity plunges them into the grave. 
Lucretivs Ca 50 BC (Hurst) 
 
 Coronary heart disease has been defined as impairment of heart function due 
to inadequate blood flow to the heart compared to its needs caused by obstructive 
changes in the coronary circulation to the heart. The most common cause of coronary 
heart disease is obstructive atherosclerotic disease of epicardial coronary arteries. 
 
 Myocardial infarction is the end result of acute massive myocardial ischemia 
due to total interruption of blood supply leading to death of cardiac muscle cells. 
Irreversible injury occurs in the area at risk and when occlusion is sustained for 4 to 6 
hours but most of the damage occurs in first 2 to 3 hours. 
 
 Although myocardial infarction mainly occurs in patients older than 40 years 
young men and women less than 40 years can also suffer myocardial infarction. The 
disease carries significant morbidity, psychological effects and financial constraints 
for the person and the family when it occurs at a young age. The protection offered by 
young age has been slowly taken away by the increased prevalence of risk factors for 
coronary heart disease in adolescents such as Dyslipoproteinemia, smoking, obesity 
and lack of physical activity. Most epidemiological data in single and cross cultural 
populations have strongly linked untreated hypertension, smoking, elevated total and 
low density lipoprotein cholesterol levels to subsequent development of coronary 
heart disease. 
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 Evidence supporting the relation between blood cholesterol and coronary heart 
disease has been strengthened by numerous animal studies showing progression and 
regression of atherosclerotic lesion as cholostrol level rise and fall by natural history 
studies of genetic hypercholestremias in which marked cholesterol elevation caused 
premature atherosclerosis even in the absence of other risk factors1. 
 
 The lipid research clinics coronary primary prevention trial (LRC – CPPT) 
study, Multiple risk factor intervention trial, Oslo trial, who multifactorial trial, north 
karelia project, life style heart trial, Stanford coronary risk intervention project have 
provided strong evidence that the increased total cholesterol level in association with 
increased incidence of coronary heart disease. 
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AIM OF THE STUDY 
 To study the serum lipid profile and the pattern of dyslipoproteinemia of 
young adults of 40 years and below with acute myocardial infarction. 
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REVIEW OF LITERATURE 
ANATOMY OF CORONARY CIRCULATION 
 
 Heart is supplied by two coronary arteries arising from the ascending aorta. 
The left main coronary artery and right coronary artery arised from the left and right 
coronary sinus just distal to the aortic wall within the 2.5 cms of it origin. The left 
main coronary artery divides in to left anterior descending artery (LAD) which runs in 
the anterior interventricular groove and the left circumflex artery (LCX) which runs 
posterior atrio ventricular groove. 
 
 The LAD gives branches to the left ventricle, the apex and anterior part of 
septum. LCX gives marginal branches to supply the posterior and inferior surface of 
the left ventricle. The RCA runs in the right atrio ventricular groove giving branches 
to supply the right atrium, right ventricle and inferior posterior aspect of the left 
ventricle. The SA node is supplied by the RCA in about 60% individuals and AV 
node in 90%. Abrupt occlusion of LCA or LCX causes infarction in the corresponding 
territory but occlusion of the left main coronary artery is usually fatal.  The venous 
system mainly follows the coronary arteries but drains to the coronary sinus and then 
to right atrium, small Eustachian veins drains directly into right atrium. 
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CORONARY ARTERY DIEASE 
 
Epidemiology : 
 Epidemics of coronary heart disease begins at different times in different 
countries. In United States epidemics began in the early 1920 and in Britan in the 
1930. The developing countries are catching up. The countries were the epidemic 
began earlier are now showing the decline. The  decline in coronary artery heart 
disease mortality in U.S has been attributed to changes in life style and related risk 
factors. The WHO has initiated project known as MONICA (Multi National 
Monitoring of Trends and Determinants in Cardio Vascular disease) To elucidate this 
crisis. To summarise in many developed countries coronary artery heart disease still 
poses the largest public health problem but even in those showing decline CAD is still 
a health problem. 
 
Coronary Artery Disease in India : 
 A large body of data exists on the occurance of CAD in hospital patients. 
However there are only two studies on its prevalence in the general population. In 
study conducted in Chandigargh urban population the prevalence was founded to be 
65.4 and 47.8 per 1000 males and females respectively. In village in Hariyana the 
prevalence was 22.8 and 17.3 per 1000 males and females respectively. However 
CAD less than 40 years was found to be less than 3% of all patients with CAD. 
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The pattern in CAD in India has been reported to be as follows. 
a) CAD appears a decade earlier compared with the age incidence in developed 
countries. The peak period is attained between 51 and 60 years. 
b) Males are affected more than females 
c) Hypertension and diabetics accounts for about 40% of all cases. 
d) Heavy smoking is responsible etiologically in a good number of cases. 
From epidemiological studies information available on the association of risk factors 
with CAD lead to the formation of number of risk factors. The risk factors classified 
into non modifiable and modifiable factors (Framingham study)2. 
Non Modifiable   Modiafiable 
Age - Cigarette smoking 
Sex - Hyper tension 
Family History - Elevated Serum Cholesterol 
Genetic Factors - Diabetes mellitus 
Personality - Obesity 
  Sedentary Habits 
  Stress 
 
 The prevalence of risk factors is on the rise in young adults and children. The 
incidence of risk factors like smoking, hyperlipidemia, diabetic mellitus, obesity, is on 
the rise in young population. Thus it becomes clear that the prevelance of the CAD is 
bound to rise in patients less than 40 years in the years to come. The under reporting 
of the illness and the challenge involved in risk factors modification in this subject of 
patients would make the management of the potentially growing problem more 
difficult. 
Bio Chemistry of Lipids : 
 The blood lipids include mainly Triglycerides, phospholipids, cholesterol and 
small amounts of free fatty acids. Blood lipids present an unique problem in 
transportation because of their isolubility in aqueous media. This problem is solved by 
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combination of lipids with the protein factions of plasma results in the formation of 
lipo protein3. 
 
Cholesterol  
 Cholesterol is an essential component of mammalian cell membrane and 
furnishes the substrate for steroid hormones and bile acids. Exists in two forms free 
and esterified forms. Most of the cholesterol in plasma circulates in the form of esters 
in the core of lipoprotein particles. The enzyme lecithin : Cholesterol acyltransferase 
forms cholesterol esters by transferring a fatty acyl chain from phosphatidyl choline to 
cholesterol. 
Triglycerides (TGL) 
 These form major fraction of lipids in the plasma lip protein complex. These 
are glycerol with fatty acids. TGL may be exogenous or endogenous in origin. 
Exogenous TGL is derived from dietary lipids and is carried in the chylomicron 
fraction of the lipoprotein. Endogeneous TGL is synthesized in the liver mostly from 
carbohydrates and is carried in the pre-beta fraction of the lipo protein. 
Phpholipids (PL) 
 The PL in the plasma are lecithin, cephalin and Sphingomyelin. The PL exists 
in the plasma mostly in association with alpha and beta globulins and are carried with 
the alpha and beta lipo proteins. 
Plasma lipoproteins  
 Lipoproteins are complexes of lipids and proteins that are essential for the 
transport of cholesterol, triglycerides and fat soluble vitamins. There are four major 
classes of lipoproteins namely Chylomicrons, Pre beta lipo proteins (VLDL). Beta 
Lipo proteins (LDL) and Alpha Lip Proteins (HDL) and new class of Lipo protein –a 
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The proteins carriers are known as Apo proteins. The types are A,B,C referred as 
Apo-A, Apo-B, Apo-C. 
Chylomicrons 
 It rich in TGL and derived from intestinal absorption of fats secreted from 
intestinal mucosal cell into the intra cellular fluids and then enter the lacteals and the 
lymphatics and finally into the systemic circulation. The apo protein components 
complex is Apo-B. 
VLDL –C : - It rich in TGL and derived from liver and secreted by intestines in a 
manner similar to that of chylomicrons. The apo proteins include Apo-B, Apo-C, The 
function of VLDL is transport of TGL from the liver to the Extra hepatic tissues. 
LDL-C : - This is particularly rich in cholesterol. Most LDL derived from intra 
vascular degradation of VLDL and chylomicrons. Approximately 70% of plasma 
cholesterol is present in the LDL form. The higher the level of LDL, the greater is the 
risk of CAD. Its Apo protein is Apo-B. 
HDL-C : - HDL contains maximum amount protein in cholesterol and phospho 
lipids. HDL and secreted from both liver and intestinal mucosa. HDL from intestines 
contains apo-A and from the liver contains apo-C. The HDL cholesterol level is 
elevated are less likely to develop CAD. 
 
Lipo Protein – A  
 Lipo Protein –A is similar to LDL in lipid and protein composition but it 
contents additional lipo protein called Apo lipo protein-a. Apo – a is synthesized in 
liver and it is attached to Apo-B 100 by a disulfide linkage. The mechanism by which 
lipo protein –a is removed from the circulation is not known. 
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Lipo Protein metabolism : 
 Lipo Protein metabolism can be thought in terms of three interconnected 
transport pathways focusing on the liver4. One exogenous pathway is responsible for 
the digestion, absorbs and tissue dissemination of dietary through in each day flows 
about 100 mg of TGL and 0.5 mg of cholesterol. Digestive enzymes in the intestinal 
lumen hydrolyse these fats to free cholesterol fatty acid mono and diglycerides which 
combine with bile salts to form the water soluble miscells responsible for carrying 
lipids to absorptive sites in the intestine. 
 
 Following their absorption into the intestinal enterocytes the components parts 
of the dietary fats are reconstituted to reform TGL and cholesterol ester which are 
packaged in chylo microns and secreted in the intestinal lymphatics through which 
they reach blood stream via thoracic duct. In the circulation TGI is gradually removed 
by action of enzymes Lipoprotein lipase located on the endothelial surface of the 
capillary beds in adipose tissue and cardiac and skeletal muscle. This process 
evicerates the chylomicrons leaving a remnant which is taken up rapidly by the liver 
depositing in the process dietary cholesterol in that organ. These sterol may be 
incorporated into hepatocytes membranes oxidized through bile acids, are repackaged 
into the endogenous TGL rich counter part of the chylomicron, the VLDL. 
 
 The liver is responsible for the continuous production of VLDL which in the 
fasting stage represents body's primary source of circulating TGL energy. The particle 
is subject to the same lipase mediated digestion process as the chylomicron, except 
that in this case the resulting particle is not cleared by the liver but instead undergoes 
additional remodeling to produce a cholesterol enriched particle (LDL) with a plasma 
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half-life of about three days. LDL is ultimately removed from the circulation by the 
high affinity LDL receptor particle or by other less well understood scavenger 
mechanisms which are thought to lead to the incorporation of LDL cholesterol into 
the atheromatous plaques. Raised level of LDL cholesterol predisposed to CAD. 
  
 In contrast to LDL, cholesterol rich HDL particles protect against CAD. They 
are synthesized in the liver and intestine and also generated in part by lipolysis of 
chylomicron and VLDL. The actual function of HDL is to remove cholesterol from 
peripheral tissues and transport for hepatic excretion. This process is thought to be 
anti atherogenic consistent with the observation that raised levels of circulating HDL 
reduces the risk of CAD. 
 
Atheroscelorosis : 
 This is a slowly progressive disease of arteries marked by elevated intimal 
fibrofatty plaques formed by lipid deposition smooth muscle cell proliferation and 
synthesis of extra cellular matrix. Large to medium sized muscular and large elastic 
arteries are involved principally in the abdominal aorta, coronary arteries, circle of 
Willis. 
 
Pathogenesis of Atherosclerosis : 
 Historically two hypo thesis for atherogenesis were dominant one emphasized 
on cellular proliferation in intima, where as the other emphasized on organization and 
repetitive growth of thrombus. The contemporary view of pathogenesis of 
Atherosclerosis incorporates element of both theories and accommodate risk factors. 
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 12
 The concept called response to  injury  hypothesis5 ,  considers atherosclerosis 
to be a chronic inflammatory response of the arterial wall initiated by injury to 
endothelium. Central to this thesis 
1) Chronic endothelial injury usually subtle with resultant endothelial 
dysfunction, yielding increased permeability leucocyte adhesion, thrombotic 
potential. 
2) Insudation of lipo proteins into the vessel wall mainly LDL with its high 
cholesterol content. 
3) Modification of lesional lipo protein by oxidation. 
4) Adhesion of blood mono cytes to endothelium followed by their migration 
into the intima and their transformation into macrophage and foam cells. 
5) Adhesion of platelets. 
6) Release of factors from activated platelets and macrophages or vascular cells, 
that cause migration of smooth muscle cell from media to intima, proliferation 
of smooth muscle cell in the intima and elaboration of extra cellular matrix, 
leading to accumulation of collagen and proteaglycans. 
7) Enhanced accumulation of lipids within cells and extra cellularly 
 
The role of Lipids in Atherosclerosis 
 Dyslipoproteinemia results either from primary and secondary causes. The 
major evidence of implicating hypercholesterolemia in genesis of atherosclerosis 
includes following : 
 
1) Genetic defect in lipo protein mechanism causing hyperlipo proteinemia are 
associated with accelerated atherosclerosis. 
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2) Other genetic factors or acquired disorders like diabetes mellitus, hypo 
thyroidisn, causes hypercholesterolemia leads to premature and  severe 
atherosclerosis. 
3) Major lipids in atheroma are plasma derived cholesterol and esters. 
4) Epidemiological analysis demonstrate a significant correlation between the 
onset of atherosclerosis and levels of total cholesterol and LDL. 
5) Lower levels of serum cholesterol by diet and drugs slows the rate of 
progression of atherosclerosis, causes regression of some plaques, reduces 
the risk of cardiovascular events. 
 
The Mechanism by which Dyslipoproteinemia contributes to Atherogenesis 
1. Chronic hyperlipidemia may directly impair endothelial cell function 
through increased production of oxygen free radicals, that deactivate 
nitric oxide, the major endothelial relaxing factor. 
2. Chronic hyperlipidemia causes lipo protein accumulation within the 
intima and at the site of increased endothelial permeability. 
3. Chemical change of lipid induced by free radicals generated by 
macrophage of endothelial cell in the arterial wall yield oxidized LDL. 
Oxidized LDL is  
a) Ingested by macrophages through the scavenger receptor 
distinct from LDL receptor forming foam cells 
b) Increased monocyte accumulation in lesions  
c) Stimulates release of growth factors and cytokines 
d) Cytotoxic to endothelial cells and smooth muscle cells. 
e) Can induced endothelial dysfunction 
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Causes of Myocardial Infarction 
1. Atherosclerosis 
2. Non Atherosclerotic causes 
 
Atherosclerosis and Myocardial infraction : 
 Atherosclerotic lesions constitute fatty sheathes and fibrous plaques. The 
fibrous plaques constitute a central core of extra cellular lipid and necrotic cell debris 
covered by a fibro muscular layer containing large number of smooth muscle cells 
macropages and collagen. In the coronary arteries raised lesions are most prominent 
in the stem, the highest incidence being a short distance beyond the ostia and it is 
nearly always found in the extramural arteries while the intramural arteries are spared. 
Selective involvement of the coronary artery may relate to unique low dynamic forces 
resulting from greater flow in diastole than systole6. 
 
Non- Atheroscelerotic Causes of CAD 
A) CAD other than Atherosclerosis  
1) Arteritis  
2) Trauma to coronary arteries  
3) Coronary mural thickening with metabolic disease of intimal proliferative 
disease . 
4)  Luminal narrowing by other mechanisms 
- Spasm of Coronary Heart Disease 
- Dissection of Aorta, Dissection of Coronary Artery 
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Emboli to Coronary Arteries 
- Infective endocarditis  
- Non Bacterial thrombotic endocarditis 
- Prolapse of mitral valve 
- Mural thrombus from left atrium, left ventricle 
- Cardiac myxoma 
- Paradoxical emboli 
 
Congenital Coronary Artery Anomaly 
- Oxygen demand supply disproportion like Aortic stenosis 
 
Hematological 
- Polycythemia  
- Thrombocytosis 
- Disseminated intravascular coagulation 
- Hypercoagulability states 
 
Miscellaneous 
- Cocaine abuse 
- Myocardial contusion 
- Complication of cardiac catheterization 
 
Risk Factors for Atherosclerosis 
It can be divided in to modified and non modified7. 
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Non modifiable (fixed) 
1. Age 
2. Sex 
3. Positive family history of CAD 
Modifiable 
1. Hypertension 
2. Diabetes mellitus 
3. Dyslipoproteinemia 
4. Smoking 
5. Obesity 
6. Physical inactivity 
7. Atherogenicdiet 
 
Emerging risk factor 8 
Lipoprotein – a 
Homocysteinuria 
Prothrombotic factors 
Pro inflammatory factors 
Impaired fasting glucose 
Sub clinical Atherogenesis 
 
1. Age 
 Age has a dominant influence on the development of clinically significant 
atherosclerosis. The process is found to progress with age. In men age > 45 years, 
women age > 55 years are associated with increased risk of atherosclerosis. In MI less 
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than 40 years various studies have shown that the highest incidence occurred between 
35 and 40 years. 
 
2. Sex  
 CAD is a leading cause of death in males after 35 years and in females after 
45 years. Various studies shows the males are increased risk of atherosclerosis after 
55 years and in females after 65 years. In women it is due to hormonal protection 
offered by oestrogen.  
 
3. Family History of Premature CAD 
 CAD often runs in families this may be due to genetic factors or the effects of 
shared environment. At present it is estimated that about 40% of the risk of 
developing IHD is condoled by genetic factors and 60% by environmental factors. 
Dyslipo proteinemia Hyper fibrinogenimia and abnormalities of other coagulation 
factors are often genetically determined. Family history of premature CAD in first 
degree in male relatives less than 55 years and in females first degree relatives less 
than 65 years are definite risk factor for atherosclerosis. 
 
4. Smoking  
 A uniquely human habit smoking has been identified as major CAD risk 
factor with several possible mechanisms. Carbon monoxide induced atherogenesis. 
Nicotinic stimulation adrenergic drive risking both blood pressue and myocardial 
oxygen demand. Lipid metabolism with fall in ‘Protective’. It has been calculated that 
in countries where smoking has been a wide spread habit, it is responsible for 25% of 
CAD deaths under 65 years of age in men. 
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Cigarattes seems to be particularly important causing sudden death from CAD, 
especially in men under 50 years of age. 
 
 The degree of risk of developing CAD is directly related to the number of 
cigarettes per day. Filter cigarettes are probably not protective. It is not only 
independent but also synergestic with other risk factors. 
 
 The risk of death from CAD decreases as cessation of smoking. The risk 
declines quite substantially within one year of stopping smoking and more gradually 
thereafter until after 10-20 years. 
 
5. Hypertension 
 The Blood pressure is the single most useful test for identifying individual at 
a high risk of developing CAD. Hypertension accelerates that atherosclerotic process, 
especially if Dyslipoproteinemia is also present and contributes importantly to CAD. 
In the Framingham study, individual with blood pressure more than 160/195 mm Hg 
had a risk of coronary artery disease is five times more than in normotensive man. 
Hypertensive men and women are affected equally with the diastolic pressue perhaps 
more important. 
 In the MRFIT study increased death rates were associated with systolic Blood 
Pressure above 110 mm Hg and diastolic BP more than 70 mm Hg. Recent 
internventional studies show that reduction of diastolic Blood Pressure levels that 
have been greater than 105 mm Hg significantly reduced the incident of IHD. 
However various studies have shown that the incidence of hypertension in young 
myocardial infarction varied from 10-20%9. 
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6. Diabetes Mellitus  
 In known diabetics both type 1 and type 2  there is atleast two fold increasing 
incidence of MI. Diabetes mellitus is a CAD risk equivalent, most patients with 
diabetes mellitus die of atherosclerosis and its complications. The abnormal 
lipoprotein profile associated with insulin resistance known as diabetic dyslipidemia 
accounts for part of the elevated cardiovascular risk in patients with type 2 diabetes 
mellitus. While diabetic patients often have LDL cholesterol near average, the LDL 
particles tend to be smaller and denser and thus more atherogenic.  Other features of 
diabetic dyslipidemia include low HDL and TGL. Hypertension also frequently 
accompanies obesity insulin resistance and dyslipidemia. Indeed the NCEPATP III 
guidelines now recognize this cluster of risk factors and provide criteria for diagnosis 
of the metabolic syndrome. The role of glucose in atheroma formation is poorly 
understood. Sorbitol a product of insulin independent aldose reductase pathway of 
glucose metabolism (Polyol pathway) accumulates in the arterial wall in the presence 
of high glucose concentration. Glycosylated LDL can be formed which may be more 
susceptible to oxidation and more redily deliver cholesterol to arterial walls than 
native LDL 
 
7. Dyslipoproteinemia 
 Although the term hyperlipidemia has long been used in clinical practice, the 
term dyslipoproteinemia more appropriately reflects the disorder of lipid and 
lipoprotein transport pathway associated with arterial disease. Abnormalities in 
plasmo lipo proteins  and derangement in lipid metabolism rank as the most firmly 
established and best understood risk factors for atherosclerosis10. Current NCEPATP 
III guidelines recommend cholesterol screening in all adults > 20 years. The screen 
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should include fasting lipid profile (Total cholesterol, TGL, LDLC, and HDLC) 
repeated every 5 years. 
 NCEPATP III11 Classification of Total, LDL and HDL cholesterol suggest 
optimal TC < 200 mg, with levels >240 mg  as high, LDL cholesterol < 100 mg as 
optimal with values > 190 mg as very high risk, HDL cholesterol value < 40 mg as 
low value. 
 
Total Cholesterol (mg) 
< 200  - Desirable 
200 – 239 - Borderline high 
> 240 - High 
 
LDL Cholesterol (mg) 
< 100 - Optimal 
100 – 129 - Near Optimal 
130 – 159 - Borderline high 
160 – 189 - High 
> 190 - Very high 
 
HDL Cholesterol (mg) 
< 40 -  Low 
> 60 -  High 
 
 In the Framingham study, cholesterol men below 40 years were clearly 
related to the future development of IHD between 35-45 years of age serum 
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cholesterol of 265 mg or over are associated with 5 times higher risk of developing 
CAD than are levels below 220 mg. In the Multiple risk factor interventional trial – 
Men with increased cholesterol more than 240 mg had a three fold increase in IHD 
compared to men who had less than 200 mg. LDL is found to be more atherogenic 
than VLDL while. VLDL has also shown to be associated with prematured 
atherosclerosis, it is more strongly associated with peripheral vascular disease. HDL 
has a protective effect and the removes cholesterol from arterial walls. 
Dyslipoproteinemia12 is found to rank second among the risk factors next to smoking 
among young MI patients. 
 Lipoprotein a has been established as an independent CAD risk factor the 
increased level of lipoprotein a is found to inhibit thrombolytic activity of naturally 
occurring tissue plasminogen activity and promote atherosclerosis. 
Classification of Dyslipoproteinemia 
It can be divided into primary and secondary  
TABLE - 1 
Primary Classification (WHO) 
Freidrickson 
type 
Genetic classification Defect Clinical sequale 
I Lipoprotein Lipase 
deficiency Apo CII 
deficiency 
Mutated or absent 
lipoprotein lipase or 
mutated lipoprotein 
lipase activator  
Pancreatitis 
II Familial 
Hypercholestrolemia  
Apo B 3500 defect 
familial combained 
hyperlipidemia 
Deficient LDL 
receptor binding, 
reduced LDL  
catabolism, over 
production of B 100 
containing particles 
CAD 
III Apo E2 homozygosity Mutated Apo E  CAD and 
peripheral 
vascular disease 
IV Familial combined 
hyperlipidemia  
Over production of B 
100 Particles 
CAD 
V Familial 
hypertryglyceridemia 
Unknown Pancreatitis 
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Secondary cause of Dyslipoproteinemia 13 
Metabolic - Diabetic Mellitus 
 - Lipodystrophy 
 - Glycogen storage disorder. 
 
Renal - Chronic renal failure, 
 - Glomerulolnephritis 
 
Hepatic - Obstructive liver disease 
 - Cirrhosis 
 
Hormone - Estrogen, Progesterone, growth hormone, hypo  
  Thyroidism, Corticosteroids 
 
Life style - Physical inactivity, obesity, diet rich in fats, and  
  Saturated fats. 
 
Medications - Retinoic acid derivatives, Glucocorticoids, anti viral  
  Drugs etc.  
 
Markers of Hyper Lipidemia  
1. Tendon Xanthomas : These are due to both intracellular and extra cellular 
deposits of cholesterol most commonly involved Achilles tendons and the 
extensor tendons of the knuckles and are found in 75% of adults with familial 
hyperlipoproteinemias. 
2. Tuberous Xanthomas which are softer, painless nodules on the elbows and 
buttocks. 
3. Xanthelasmas which are barely elevated deposits of cholesterol on the eye lids 
are more common in Heterogeneous familial hyperlipoprotinemias. 
4. Eruptive Xanthomas 
5. Xanthoma retinalis 
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`TABLE - 2 
SUMMARY OF MAJOR DRUGS USED FOR DYSLIPOPROTEINEMIA 
Drug Mechanism Lipoprotein 
effect 
Indication 
HMG – coA 
reductase 
inhibitors  
Lovastation 
Pravastatin 
Simvastatin 
Atorvastatin 
Rosuvastatin 
↓ Cholesterol Synthesis  
↓ Hepatic LDL receptor 
↓ VLDL production 
LDL ↓ 18-55% 
HDL ↑ 5-15 % 
TGL ↓ 7-30 % 
Elevated LDL 
Bile acid 
sequestrants  
Cholestyramine 
Colestipol 
↑ Bile acid excretion,  
↑ LDL receptor  
LDL ↓ 15-30% 
HDL ↑ 3-5 % 
TGL no change 
Elevated LDL 
Nicotinic acid ↓ VLDL hepatic synthesis LDL ↓ 5-25% 
HDL ↑ 15-35 % 
TGL ↓ 20-50% 
Elevated LDL, 
Low HDL 
Elevated TGL 
Fibric Acid 
derivatives  
Fino fibrate 
Gem fibrozil 
↑ LPL ↓ VLDL  
Synthesis 
LDL ↓ 5-20% 
HDL ↑ 10-20 % 
TGL ↓ 20-50% 
Elevated TGL, 
Elevated 
remnants 
Cholesterol 
Absorption 
inhibitors  
↓ Intestinal cholesterol 
absorption 
 
 Elevated LDL 
 
Management of Dyslipoproteinemia 
 
 According to NCEP – ATP III identify elevated LDL cholesterol as the 
primary target of cholesterol lowering therapy. Three categories of risk that modify 
LDL Cholesterol goals are : 
1.CAD and CAD risk equivalent, - < 100 mg 
2. Multiple 2+ risk factors-<130 mg 
3. Zero to one  risk factors - < 160 mg 
For category one lifestyle changes at  > 100 mg, Drug therapy at > 130 mg, category 
two lifestyle changes at >130 mg drug therapy at > 160 mg, for category three 
lifestyle changes at > 160 mg drug therapy > 190 mg. 
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Elevated Triglycerides  
 Two approaches lifestyle changes and drug therapy. First reduction of LDL 
cholesterol and addition of nicotinic acid or fibric acid. 
 
Lower HDL cholesterol 
 In all patients with Low HDL cholesterol the primary target of therapy is LDL 
cholesterol and there is isolated low HDL cholesterol drugs for raising HDL 
cholesterol is considered and is mostly reserved for persons with CAD and CAD risk 
equivalent. 
 
8. Obesity  
 It is the most common nutritional disorder in affluent societies. Its 
significance requires constant emphasis since it is associated with increased mortality. 
The presence of obesity detected in myocardial infarction patient less than 40 years 
ranged from 5-20%14. Central obesity was more important as it is associated with 
insulin resistance of peripheral tissues and compensatory Hyper insulinaemias, 
enhanced production of TGL and cholesterol rich proteins by liver. Obesity is related 
to atheroscelarosis both directly and via Hypertension Hyper Tryglyceridaemia, 
Hyper cholesterolaemia and hyper glycaemia. Obesity is assessed by bodymas index. 
BMI > 30 is considered as obesity. Obesity is assessed by waist circumference 
measurement. In Men > 40” and women > 35” indicates abdominal obesity. 
 
9. Physical Inactivity   
 Among prospective studies, the Framingham data indicates that the less 
sedentary an individual, is the less susceptible to sudden death following CAD. 
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 Exercise ameliorates the hyper lipidemia by increasing caloric expenditure15. 
Extensive clinical experience have revealed the importance of exercise affecting both 
left ventricular function and the atheroscelorotic process and improving the prognosis 
after the coronary event. Physical activity increased the level of HDL. 
 
10. Personality A 
 Type A behaviour is associated with competitive drive, restlessness, 
hospitality, and a sense of urgency or impatience. Type A individuals are more prone 
to CAD than calmer, more philosophical type B individual. 
 
11. Diet  
 Diet rich in fat and cholesterol increases the chances of getting CAD Plasma 
cholesterol and LDL levels are sensitive to the amount of saturated fat and cholesterol 
in diet. The average cholesterol level in most closely related to the amount of animal 
fats (Meat, egg, milk). Decreased intake of complex carbohydrates and vegetable fibre 
leads to hyper cholesterolaemia. The dietary poly-unsaturated / saturated fat ratio is 
gaining importance. Low levels of Vitamin C, Vit.E and other anti oxidants enhance 
the prediction of oxidized LDL. 
 
Emerging Risk Factors 
 A large body of literature suggest a relationship between 
hyperhomocysteinemia and CAD. Several mutations in their enzyme pathway causes 
accumulation of homocysteine which is associated with coronary risk and thrombosis. 
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 An accumulation of clinical evidence shows that markers of inflammation 
correlates clinical risks. For example elevated C reactive protein and fibrinogen are 
associated with increased risk of CAD. One source of inflammatory stimulus could 
arise from infectious agent. 
 
Issue in Risk Assessment 
 A growing panel of markers of coronary risk presents perplexing array to the 
practitioner. Markers measured in peripheral blood includes size fractions of LDL 
particles, concentration of homocysteine, LP(A), fibrinogen, C reative protein. In 
general such special test add little to the information available from careful history 
and physical examination, combined with measurement of plasma lipoprotein profile 
and fasting blood sugar. Similar concerns pertain to the use of specialized radio 
graphic estimation of coronary artery calcification. 
 
The challenge of Implementation 
 We must learn how to help individuals adopt a healthy life style, and learn to 
deploy over increasingly powerful pharmacology tools most economically and 
effectively. The obstacles to implementation are economics education, physician 
awareness and patient adherence to recommended regime. 
 
Clinical presentation of myocardial infarction in the young patient  
 The clinical presentation of acute MI in young adults differs from their 
older counter parts. The classic presentation of worsening angina culminating 
in MI is rare in younger patient. The first onset of angina that rapidly progress 
to fully evolved MI is often  the case in patient less than 40 years of age16. 
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 The prevalence of stable angina in young adults with reported coronary 
artery diseases was only 24% in one study17. In a series of patients who had 
their MI less than 40 years denied chest pain before MI18. The duration of 
symptoms was found to be less than a week in most of the patient. Careful 
history taking would be important clues as to the differential diagnosis of 
chest pain. In every young patient presenting with MI use of recreational 
drugs in the recent times should be recorded. Family history of premature 
CAD, smoking, obesity, diabetes  and dyslipidemia19 would give better clue 
to the likely hood of atheromatous coronary diseases. History of recurrent 
venous and arterial thrombosis should also be reported 20. 
 Initial clinical examination should concentrate on hemodynamic 
stability, evidence of sympathetic hyperactivity such as tachycardia and 
sweating, and evidence of previous injected drug used. Stigmata of 
dyslipidemia such as xanthelesma arcus senilis and tendon xanthomata should 
be looked for in every person the precordium is usually quiet and there may 
be abnormal systolic pulsations in the apical area, sign of ventricular 
dysfunction like S3 and S4, decreased intensity of heart sounds and an apical 
systolic murmur due to  mitral regurgitation. There may be pericardial friction 
rub. Mild elevation of temperature and small drop in blood pressure may also 
be noted in some cases. 
Complication of myocardial infarction: 
1. Rhythm disturbance-Sinus Brady cardia, AF, VF 
2. Heart failure 
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3. Mitral Regurgitation 
4. Pericarditis 
5. Thromo embolism 
6. Ventricular septal rupture 
7. Post infarction extension 
8. Dressler’s syndrome 
9. Ventricular aneurysm 
10. Cardiac rupure 
Ventricular Function in myocardial infarction 
 It has been found that after a brief episode of ischaemia, prolonged 
dysfunction with gradual return of contraction activity occurred, a condition 
termed myocardial stunning. It has become clear that chronically depressed 
myocardial function would be ameliorated, probably by relief of ischemia 
termed ‘Myocardial hibernation’ 
Systolic Dysfunction 
 The fundamental pathological alteration underlying LV dysfunction in 
MI is loss of functioning myocardium. Cessation of blood flow to a region of 
mycaordium produces four sequential abnormal contraction pattern. 
1. Dysynchrony – disassociation of the time course of contraction of 
 adjacent segments of myocardium. 
2. Hypokinesis – reduction in the extent of shortening 
3. Akinesis – Cessation of shortening. 
4. Dyskinesis – Paradoxial expansion and systolic bulging. 
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Diastolic Dysfunction 
  Ventricular diastolic properties are altered in infarction and ischaemic 
myocardium, leading initially to an increase but later to a reduction in left 
ventricular compliance. These changes are associated with an initial rise in 
Left Ventricle end Diastolic pressure over a period of two weeks. This 
pressure tends to fall towards normal. 
Right Ventricular infarction 
 It generally associated with obstructive lesions of the right coronary 
artery. However it occurs less commonly than would be anticipated form the 
frequency of atherosclerotic lesions involving the right coronary artery. This 
discrepancy can be explained by the lower oxygen demands of the right 
ventricle. More over the inter coronary collateral system is richer and thinner 
of the right ventricular wall allows the chamber to derive some nutrition from 
the blood within its cavity. 
Ventricualr remodeling and infarct expansion 
 As a consequence of myocardial infarction changes in left ventricular 
in left ventricular size, shape and thickness involving both the infarcted and 
non-infarcted segments of the ventricle often occur. These changes referred to 
as ventricular remodeling can influence LV function and prognosis. An 
increase in the size of the infarcted segments knows as ‘infarct expansion’ is 
defined as acute dilatation and thinning of the area of infarction explained by  
additional myocardial necrosis. 
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MATERIALS AND METHODS  
 Seventy patients with established acute myocardial infarction in the 
age group of 40 years  and below in Coimbatore medical college hospital 
admitted under cardiology unit and its corresponding medical units were 
studied during the period of January2005 to December 2005. All the cases 
were studied in detail from admission to discharge and followed regularly for 
one month after the admission. 30 healthy age and sex matched persons 
(controls) were studied simultaneously. Detailed history was taken from all 
the patients. Enquiries were made regarding the site, nature, duration of the 
chest pain, accompanying symptoms like breathlessness, vomiting, nausea, 
fatigue and palpitation. 
 The diagnosis of myocardial infarction was made by the classic world 
health organization (WHO)21 criteria for the diagnosis of myocardial 
infarction which requires that at least two of the following three elements to 
be present, history of ischemic type chest discomfort, evolutionary changes on 
serially obtained ECG tracing, rise and  fall in serum cardiac markers. 
On General Examination 
 Anaemia, Cyanosis, Sweating, Pulse, B.P, JVP, Height, weight in kgs, 
features of hyperlipidaemia like xanthalesma, Xanthoma, Pedal edema. 
 Complete systemic examination of CVS, RS, Abdomen and CNS done. 
Complete history about risk factors analysis was taken with regard to 
smoking, DM, family history of CAD, Hypertension, Hyper Lipidemia, 
Lifestyle and physical activity, obesity, or drug intake. 
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 The BMI was calculated from the formula weight in Kgs/Height in M2. 
The waist circumference is the minimum circumference measured between 
the costal margin and iliac crest and hip circumference over the buttocks. 
The following investigation were done for all patients. 
1. Urine – Albumin, Sugar, Deposits 
2. Blood – Urea, Sugar, Lipid profile (Fasting) 
3. Serum- Creatinine, CPK- MB [> 8 IU/dl is abnormal] 
4. ECG 
5. X-Ray Chest PA View 
6. Echo Cardiography 
Localisation of myocardial infarction from ECG 22 
Lead I, a VL, V1- V6- Extensive anterior 
V1 – V6- Antero Lateral 
V1-V4- Antero septal 
Lead 1, a VL, V4-V6-Antero lateral 
V5-V6 – Apical 
Lead II, Lead III, a VF- Inferior wall 
V3R, V4R – RV infarction 
 
 Echocardiography was done for all patients for assessing the 
ventricular function, regional wall motion abnormalities, presence of 
thrombosis and pericardial effusion. X-Ray PA View was taken to detect 
cardiomegaly features of pulmonary edema and pleural effusion. 
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Lipid profile 
 Lipid profile was done with standard procedure. Blood was drawn in 
the morning before breakfast (Fasting 12 hours). It is preferable to collect 
blood in tubes without anti coagulant (for serum) but it is possible to use tubes 
containing EDTA. The lipid fractions were done in the following methods 23. 
Total Cholesterol (SALKOWSKI’S METHOD) 
 The principle of this reaction is that cholesterol reacts with ferric 
chlorideions in acetic acid followed by sulphuric acid. This method is 
modified by ‘WYBENGA’ and this method is used to estimate total 
cholesterol level. 
HDL Cholestrol (Loper and Virella) 
 In this procedure, the VLDL, Chylomicrons, LDL were precipitated by 
phosphotungstate in the presence of Mg+ ions and the cholesterol is estimated 
from the supernatant. All measurements were taken using highly sophisticated 
modulab system of Boheinger Knoll West Germany. 
Triglycerides (Foster and Dunn Hantzsh Reaction) 
 In this reaction TGL are extracted by Haptane and Saponified by 
potassium hydroxide. The glycerol is oxidized to formaldehyde which 
combines with acetyl acetone in the presence of ammoniumions to give a 
dihydrobutidine derivative which is measured calorimeterically at 415nm. 
 The LDL cholesterol is calculated from the above lipid profile values 
using the formula – Friedwald. 
Totalcholesterol – HDL Cholesterol – TGL/5=LDL Cholesterol 
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Test of Significance24 
1. Normal deviate or Critical Ratio 
ND  = 
n
X
/σ
μ−  
ND – Normal Deviate 
X – Character of Variable Tested in Sample  
μ  - Character of Variable Tested in Population 
n/σ  - Standard Error of Sample Character  
If – Normal Deviate > 2 indicates P < 0.05, test is significant 
2. Standard Error of Difference between two proportions 
SE = 
2
22
1
11
n
qp
n
qp +  
p1 - % of patients with risk factor 
q1 - % of  patients of without risk factor 
p2 - % of controls with risk factor  
q2 - % of controls without risk factor 
n1 – Number of study population 
n2- Number of control population 
If observe difference between the two groups is  more than twice that of 
standard error, the test is significant. 
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3. Standard Error of Difference between two means 
S.E
2
2
1
1 22
nn
σσ +  
1σ  - Standard Deviation of Study population 
n1 – Number of study population 
2σ  - Standard Deviation of control population 
n2 – Number of control population 
 If the actual difference between the two means is more than twice that 
of standard error of difference between, two means then the test is significant. 
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RESULTS AND OBSERVATIONS 
The results and observations of the study were presented below  
Age Distribution 
 The mean age of study group was 35.271 from 20-40 years. The mean 
age of control group was 35-64 ranging from 22-40 years. The pattern of 
distribution was 
Table - 3 
Age Distribution 
 
                   Patient 
Age in years Number Percentage 
<20 - - 
20-30 10 14.28 
31-35 20 28.56 
36-40 40 57.14 
 
Most of the cases were in age group of 31-40 years (85.64%) 
Sex Distribution 
Among 70 patient 68 were males and 2 were females. 
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Table - 4 
Sex Distribution 
  
 
 
Anthropometry 
 The mean height of our study cases were 166.43cm and weight 
67.16kg. The mean height of control group were 166.2cm and weight was 
64.44kg. The mean body mass index of the study cases was 24.27 and of 
control was 23.26 
Incidence of Smoking 
 According to the number of beedies, cigarettes smoked per day they 
are divided in to 3 groups  
Table - 5 
Incidence of smoking 
 
 
 
 
 
 
                   Patient 
Sex Number Percentage 
Male  68 97.15 
Female 2 2.85 
                  Patient 
Cigarettes or 
beedies  per day 
Number Percentage 
None 49 70 
<20 12 17.15 
>20 9 12.85 
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 All the smokers were male, smokers form 30% among study group. 
The duration of smoking was more than 10-15 years 
Incidence of obesity 
 There were about 28 patient who had a body mass index more than 30 
Table - 6 
Incidence of obesity 
 
 
 
 
Incidence of Hypertension 
 There were 8 cases established Hypertension among the study cases 
who were on treatment  
Table - 7 
Incidence of Hypertension 
  
 
 
Incidence of Diabetes Mellitus 
 There were about 12 cases of established diabetes mellitus among 
study group. 
  
 
                  Patient 
Body mass index Number Percentage 
>30 28 40 
No of cases  Percentage 
8 11.42 
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Table -8 
Incidence of Diabetes Mellitus 
 
 
 
Family History of CAD  
 About 21 of the study group had family history of MI among blood 
relatives  
 
Table - 9 
Incidence of Family History of CAD 
 
 
 
Sedentary Life style 
 Among the study group 18 of the cases were in sedentary life style 
Table - 10 
Incidence of Sedentary Life Style 
 
 
 
 
 
No of cases  Percentage 
12 17.14 
No of cases Percentage 
21 30 
No of cases Percentage 
18 25.7 
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LIPID PROFILE 
a. Total Serum Cholesterol 
 The mean total serum cholesterol of study group was 217.2mg and that 
of control was 177.46mg 
Table - 11 
Mean total Serum Cholesterol 
 
 
 
 The standard error of difference between two means of  two groups 
was 15. The observed difference between two means was more than twice 
that of standard error of difference between means of two groups there fore 
the result was significant . 
 
b. Incidence of Hypercholesterolemia   
 There is about 50% increase in the level of cholesterol > 200 mg in the study 
group, compared to about 26.66 % in control. 
Table - 12 
Incidence of Hypercholesterolemia 
 
 
 
 Normal deviate is 2.4, it implies P<0.05, there is significant incidence of 
Hypercholesterolemia in study population. Standard error of difference between 2 
Study Group in mg% Control group in mg% 
217.2 177.46 
Study Group Control group 
Number Percentage Number Percentage 
35 50 8 26.66 
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proportions is 10.03, the observed difference is more than twice that of standard error 
of difference, there fore the result was significant. 
c. Serum Low Density Lipoprotein Cholesterol 
 The mean level of LDL-C in study group was 132 mg and the control group 
was 1.5 mg. 
Table - 13 
Mean Level of LDL Serum Low Density Lipoprotein Cholesterol 
 
 
 
 
 The standard error of difference between two means of  two groups was 
10. The observed difference between two means was more than twice that of 
standard error of difference between means of two groups there fore the result 
was significant. 
d. Incidence Of High Risk Low Density Lipoprotein Cholesterol 
 There is about 35.71 % increase in the level of LDL cholesterol > 130 mg in 
the study group, compared to about 23 % in control. 
Table - 14 
Incidence of High Risk Low Density Lipoprotein Cholesterol 
 
 
 
 
Study Group in mg % Control group in mg% 
132 105 
Study Group Control group 
Number Percentage Number Percentage 
25 35.7 5 16.6 
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 Normal deviate is 2.6, it implies P<0.05, there is significant incidence of High 
Risk LDLC in study population. The standard error of difference between two 
proportions was 8.88, the observe difference is more than twice that of standard error 
of difference, there fore the result was significant. 
e. Serum Triglycerides 
 The mean level of TGL in study group was 167.5 mg and the control group 
was 110 mg. 
Table - 15 
Mean Level of Triglycerides 
 
 
 
 
 The standard error of difference between two means of  two groups was 
15. The observed difference between two means was more than twice that of 
standard error of difference between means of two groups there fore the result 
was significant. 
f. Incidence of Hyper Triglyceridemia 
 There is about 47.14 % increase in the level of TGL in the study group, 
compared to about 26.6 % in control. 
Table - 16 
Incidence of Hyper Triglyceridemia 
 
 
 
Study Group in mg% Control group in mg% 
167.2 125.65 
Study Group Control group 
Number Percentage Number Percentage 
33 47.14 8 26.6 
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 Normal deviate is 2.8, it implies P<0.05, there is significant incidence of 
Hyper Triglyceridemia in study population. The standard error of difference between 
two proportion is 10.03, the observed difference was more than twice that of standard 
error of difference between two proportions, indicating the result was significant. 
 
g. High Density Lipoprotein Cholesterol 
 The mean level of HDLC in study group was 50.9 mg and the control group 
was 50 mg. 
Table -17 
Mean Level of High Density Lipoprotein Cholesterol 
 
 
 
 
 There is no significant difference between the means of 2 groups. 
h. Incidence of Highrisk High Density Lipoprotein Cholesterol 
 There is about 40 % increase in the level of High Risk HDLC in the study 
group, compared to about 20 % in control. 
Table - 18 
Incidence of High Risk HDLC 
 
 
 
 
Study Group in mg% Control group in mg% 
50.9 47 
Study Group Control group 
Number Percentage Number Percentage 
28 40 6 20 
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 Normal deviate is 2.6, it implies P<0.05, there is significant incidence of 
Highrisk HDLC in study population. The standard error of difference between two 
proportion was 9.36, the observe difference was more than twice that of standard error 
of difference between two proportions, indicating the result was significant. 
 
Table - 19 
Diabetis Mellitus and Lipid Profile 
 No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
With Diabetes 12 229 57.5 137.41 173.7 
Without Diabetes 58 213 53.2 126.5 166.5 
 
Table - 20 
Hypertension and Lipid Profile 
 No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
With Hypertension 8 258 62 153 200 
Without Hypertension 62 210 53 125 163 
 
Table - 21 
Smoking and Lipid Profile 
 No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
With Smoking 21 225 58 123 175 
Without Smoking 49 212 52 130 165 
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Table - 22 
Obesity and Lipid Profile 
 No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
With Obesity 28 212 46.2 133 162 
Without Obesity 42 218 59 125 175 
Table - 23 
Sedentary Life Style and Lipid Profile 
No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
18 282 63 149 198 
Table - 24 
Family History of CAD and Lipid Profile 
No of 
Patients 
Total 
Cholesterol 
(Mean mg/dl) 
HDLC 
Mean 
Mg/dl 
LDLC 
Mean 
Mg/dl 
 
TGL 
Mean 
Mg/dl 
21 236 56 142 167 
Anatomical Distribution of Myocardial Infarction 
AREA INVOLVED NO. PERCENTAGE
  
Extensive Anterior wall 8 11.4 
Antero Septal 20 28.5 
Antero Lateral 10 14.3 
Inferior Wall 18 25.7 
Inferior Wall with RV Extension 6 8.6 
True Posterior wall 2 2.85 
Anterior and Inferior wall 6 8.6 
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Table - 25 
 
Incidence of ST Elevation MI and Non ST Elevation MI 
 
Type Number Percentage 
ST Elevation 67 96 
Non ST Elevation 3 4 
 
 
Complications During Hospital Stay 
Complications No. Percentage 
  
1. Rythm Disturbance  
 Ventricular Premature beats 12 17 
 Sinus Bradycardia 10 14 
 Left bundle branch block 6 8.5 
2. Left Ventricular failure 18 25.5 
3. Death Mortality 3 4 
 
Echo Cardio Gram 
 All patients were subjected to Echo. About 25 patients shows left ventricle 
systolic dysfunction (35.7%) left ventricular clot 2 patients (3%). 
 
X-ray Chest PA View 
 X- ray Chest PA View was taken to all patients for evaluation of Cardiomegaly 
and features of congestive cardiac failure. Only 7 patients showed features of failure. 
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DISCUSSION 
 
 The conquest over infectious disease have enhanced the importance of 
preventive cardiology, because of the increasing size of adult population and higher 
incidence of MI in the 4th decade and beyond. The risk factors includes increasing age 
male sex, Dyslipoproteinemia, Hypertension, Diabetes Melitus, Smoking, Obesity, 
Family History of CAD and lack of physical inactivity. 
 
 Our hospital incidence shows that there is steady increase in MI altogether, 
especially among young adults of 40 years and below.  
 
Age Incidence 
 The maximum incidence of MI is between 36 to 40 years. The data is 
comparable to the study conducted by K.N Pradeep et al 25 and S. Tewari                    
et al 26. 
Table - 26 
Age Incidence 
Series Year Mean Age 
K.N. Pradeep  et al 2004 36.8 
S. Tewari et al 2005 37.4 
Present 2005 35.271 
 
Sex Incidence  
 Among 70 cases studied only two are females. The sex incidence of male and 
female were 97.15 : 2.85, which was comparable to other studies conducted in India 
by Chandurkar27, B.L. Agarwal28, S. Tewari.  
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Table - 27 
Sex Incidence 
Series Year Male Percentage Female Percentage 
Chandurkar 1971 95.2 4.8 
B.L. Agarwal 1978 93.5 6.5 
S. Tewari 2005 92 8 
Present 2005 97.15 2.85 
 
Diabetes Melitus 
 There were 12 cases of established diabetis melitus who were taking treatment 
in study group. This was comparable to the studies conducted by S. Sharma et al 29,  
S. Ravishankar et al 30 on young MI patients in India. 
Table - 28 
Incidence of Diabetes Melitus 
Series Year Male Percentage Female Percentage 
Sharma et al 2002 12 20% 
S. Ravisankar et al 2002 23 22% 
Present 2005 12 17.14 
 
Overall  diabetes melitus did not formed major risk factor for young MI. 
 
Hypertension 
 There were eight patients with established systemic hypertension. The 
incidence of hypertension is 11.42% in the present study which is comparable to other 
studies conducted in India by Chandurkur et al, S. Sharma et al, J. Ismail et al31, in 
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young MI patients. This study shows that hypertension does’nt appears to be primary 
cause of advanced atherosclerosis in the population of young. 
 
Table - 29 
Incidence of Hypertension 
Series Year No. Percentage 
Chandurkur et al 1971 9 14.5 
S. Sharma et al 2002 9 15 
Ismail et al 2004 20 14 
Present 2005 8 11.42 
 
Smoking 
 There were about 21 patients of smokers in the present study. This was 
comparable to other studies conducted by D.K. Baruah et al32, Gurupar Singh et al33, 
K.N. Pradeep et al, on young MI patients. 
Table - 30 
Incidence of Smoking 
Series Year No. Percentage 
D.K. Baruah et al 2004 89 32.2 
Gurupar Singh et al 2002 20 40 
K.N. Pradeep et al 2004 19 30 
Present 2005 21 30 
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Obesity  
 The number of obese patients in the study group was 38. This was comparable  
to other studies conducted by K.N. Pradeep et al and K.W. Alwash et al 34. 
Table - 31 
Incidence of Smoking 
Series Year No. Percentage 
K.N. Pradeep et al 2004 22 34 
K.W. Alwash et al 2003 61 28 
Present 2005 28 40 
 
SERUM LIPID PROFILE 
a. Serum Mean Total Cholesterol 
 The Mean Serum Total Cholesterol was significantly elevated in the study 
group when compared to controls. This values are comparable to studies conducted by 
J.K. Mishra et al 35, and Santanu Guha et al 36. 
Table - 32 
Serum Mean Total Cholesterol 
Series Year Study group mg%. Control group mg%. 
J.K. Mishra et al 2001 224 180 
Santanu Guha et al 2001 216 185 
Present 2005 217.2 177.46 
 
 These values were also comparable to other studies conducted on young MI 
patients by Nevas et al 37, and Corvilan. B et al 38,  
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b. Incidence of Hyper Cholesterolemia 
 There is significant increase in the incidence of patients with High Risk 
Cholesterol (P < 0.05) which was comparable to the studies conducted by Rajeev 
Gupta et al 39, S. Tewari et al, on young MI patients. 
Table - 33 
Incidence of Hyper Cholesterolemia 
Series Year 
Study Group Control Group 
No Percentage No Percentage 
Rajeev Gupta et al 2001 253 48.8 100 15 
S. Tewari et al 2005 44 40 12 12 
Present 2005 35 50 8 26.66 
 
 In over 20 prospective studies in difference countries, total serum cholesterol 
level has been shown to be related to the development of CAD as in Multiple Risk 
Factor, Intervention trials (MRFIT) by Stamler J et al 40. In the study group the 
incidence of Hyper Cholesterolemia was noted in 50 % thus there is significant 
elevation of total cholesterol in study group when compared to controls, which is 
comparable to other studies conducted by Chowdry et al 41 on MI in young patients.  
 
c. Serum Low Density Lipoprotein Cholesterol 
 The mean level of High Risk LDLC in the study group was 132 mg which is 
significantly elevated then control, which was 98 mg. This increased level of LDLC 
was comparable to other studies conducted by Jacob V Jose et al 42 and S. Tewari               
et al. 
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Table - 34 
Mean Serum Low Density Lipoprotein Cholesterol 
Series Year Study group mg% Control group mg% 
Jacob V Jose et al 2004 134 100 
S. Tewari et al. 2005 121 96 
Present 2005 132 105 
 
 Increased LDLC is Atherogenic which was proved in many studies like studies 
conducted by Kwame O Alwash et al and Rodney G Bowden et al 43. 
 
d. Incidence of High Risk Low Density Lipoprotein Cholesterol 
 There is significant increase in the incidence of High Risk LDLC (P<0.05) 
which is comparable to other studies conducted by Jacob V Jose et al, S. Tewari et al, 
UHL GS et al, M Egred 44 on studies of Risk Factors in young MI. 
Table - 35 
Incidence of High Risk Low Density Lipoprotein Cholesterol 
Series Year 
Study Group Control Group 
No Percentage No Percentage 
Jacob V Jose et al 2004 121 41 80 20 
S. Tewari et al 2005 45 41 20 21 
Present 2005 25 35.71 5 16.6 
e. Serum Triglycerides 
 The Mean Serum Triglycerides is significantly elevated in study groups 
comparing to control, which is comparable to other studies conducted by Issar et al 45,   
Jacob V Jose et al, G. Morgan et al 46, Zimmerman FH et al47, 
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Table - 36 
Mean Serum Triglycerides 
Series Year Study group mg% Control group mg% 
Issar et al 2001 202 148 
Jacob V Jose et al 2004 142 120 
Present 2005 167.5 125.65 
 
f. Incidence of Hyper Triglyceridemia 
 There is significant increase in the incidence of High Risk TGL (47.14%, 
P<0.05) in the study group, which was comparable to studies conducted by Jacob V 
Jose et al, S. Tewari et al, A.L. Yusuf A.R.48 and curren PJ et al 49. 
Table - 37 
Incidence of Hyper Triglyceridemia 
Series Year 
Study Group Control Group 
No Percentage No Percentage 
Jacob V Jose et al 2004 127 43.8 74 30 
S. Tewari et al 2005 45 41 24 32 
Present 2005 33 47.14 8 26.6 
 
g. High Density Lipoprotein Cholesterol 
 The level of HDLC < 40 mg is definite Risk Factor for Atherosclerosis 
however in our present study there is no significant reduction in HDLC. But in studies 
conducted by Issar et al, S. Tewari et al, Showed reduced HDLC. 
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Table - 38 
Mean High Density Lipoprotein Cholesterol 
Series Year Study group mg% Control group mg% 
Issar et al 2001 30.16 46.8 
S. Tewari et al 2005 33 60 
Present 2005 50.9 47 
 
h. Incidence of High Risk High Density Lipoprotein Cholesterol 
 There is significant increase in the incidence of High Risk HDLC in the study 
group 40% (P<0.05) which was comparable studies conducted by S. Tewari et al 
Usula S. et al 50, Siwash et al 51. 
Table - 39 
Incidence of High Risk High Density Lipoprotein Cholesterol 
Series Year 
Study Group Control Group 
No Percentage No Percentage 
S. Tewari et al 2005 69 62.7 32 40 
Present 2005 28 40 6 20 
 
Family History of Coronary Artery Disease 
 Family History of CAD forms a significant Risk Factor in the development of 
early atherogenisis and MI in the present study the incidence was 30% which was 
comparable to other study conducted by Issar et al. 
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Table - 40 
Incidence  of Family History of  CAD 
Series Year No. of Cases  Percentage 
Issar et al 2001 12 24 
Present 2005 21 30 
 
Sedentary Life Style 
 The incidence of sedentary life style was 27% in the present study which was 
comparable to study conducted by Chadurkur et al, on MI in young.  
Table - 41 
Incidence  of Sedentary Life Style 
Series Year No. of Cases  Percentage 
Chadurkur et al 1971 20 28.2 
Present 2005 18 27 
 
Diabetes Melitus and Lipidprofile 
 The pattern of Lipidprofile in Diabetic patients in the present study was  
Table - 42 
Diabetes Melitus and Lipidprofile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
12 17.14 229 173 57.5 137.41 
 
 This is comparable to study conducted by Vusal H et al 52, which shows Serum 
Cholesterol – 233 mg, TGL – 173 Mg, HDLC – 38 mg, LDLC – 137 mg. There is 
increase incidence of Hypercholesterolemia, Hypertriglyceridemia, increased level of 
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LDLC as shown in study conducted by Mohamed Ishak et al 53 on Hyperliipidemia in 
Diabetis Melitus. 
   
Hyper Tension and Lipidprofile 
 The pattern of lipid profile in the present study with hypertensive patients was  
 
Table - 43 
Hyper tension and lipid profile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
8 11.42 258 200 62 153 
 
 There is increased incidence of elevated total cholesterol, TGL, LDLC. It is 
comparable to study conducted by Malhotra et al 54, Isolated lipid abnormalities in 
rural and urban hypertensive patients in north India and study conducted by AB 
Bhavani et al 55 on lipid profile and apolipoprotein E polymorphism on essential 
hypertension. 
Smoking and Lipidprofile 
 The pattern of lipid profile in the present study with smoking in the presence 
study was     
  Table - 44 
Smoking and Lipidprofile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
21 30 225 175 58 123 
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 There is increased incidence of elevation total cholesterol TGL and low 
density lipoprotein cholesterol. In the study conducted by Ns Neki et al 56, lipid 
profile in chronic smokers, shows increased incidence of total cholesterol (181 mg) 
Triglycerides (173mg), Low density lipoprotein cholesterol (103mg) when compared 
to control. It is also comparable other studies conducted by Restogi et al 57, On lipid 
profile  in smokers  and Muscat je et al 58 on cigarettes smoking and plasma 
cholesterol. 
Obesity and Lipidprofile 
 The pattern of lipid profile in the present study shows elevated total 
cholesterol, TGL and LDLC.    
 
Table - 45 
Obesity and Lipidprofile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
28 40 212 162 46.2 133 
 
 The pattern was seen in studies conducted by Abdulhamid et al 59 which 
shows total cholesterol 215mg, TGL- 189 mg, LDLC-135mg. It was also comparable 
to the study conducted by DK Baruah et al  
Sedentary Lifestyle and Lipidprofile 
 There is significant increase in total cholesterol, TGL and LDLC in this group     
Table - 46 
Sedentary Life Style and Lipid Profile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
18 27 282 198 63 149 
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 It was comparable  to the study conducted by Rodney G Bowden et al on lipid 
level of sedentary university students. 
Family History of CAD and Lipidprofile 
 There is significant increase in total cholesterol, TGL and LDLC in this group     
Table - 47 
Family History of CAD and Lipidprofile 
No. of patients Percentage Total 
Cholesterol Mg. 
TGL 
Mg 
HDLC 
Mg 
LDLC 
Mg 
21 30 236 167 56 142 
 This was compared to study conducted by Chandurkar et al which was shows 
similar pattern 
Anatomical Distribution of Myocardial Infarction 
 The pattern of  Anatomical distribution of myocardial infarction in the 
presence study shows most of the involvement of anterior wall, which is 
comparable to the study conducted by S. Sharma et al which  shows anterior 
wall 35 patients (58.3%), Inferior wall 23 patient (38.3%), Right ventricle 2 
patients (3 %) 
    Table -48 
 Anatomical distribution of myocardial infarction 
Area involved Number Percentage 
Extensive Anterior wall 8 11.4 
Anteroseptal wall 20 28.5 
Anterolateral wall 10 14.3 
Inferior wall 18 25.7 
Inferior wall and right ventricle 6 8.6 
True posterior wall 2 2.85 
Anterior and inferior wall 6 8.6 
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ST Elevation and non ST elevation Myocardial Infarction 
 Most of the cases were ST elevation myocardial infarction in the present 
study (96%)  
Table - 49 
ST Elevation and Non ST Elevation Myocardial Infarction 
 
Type Number Percentage 
ST Elevation 67 96 
Non ST Elevation 3 4 
 
 This is comparable to the study conducted by CVN Murthy et al 60 which 
shows ST elevation MI incidence of 93% 
Mortality 
 In the presence study 3 cases died of severe left ventricular dysfunction (4%) 
which was comparable to the study conducted by Chandurkar et al  which shows 
mortality of 4 cases (6.7%) 
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CONCLUSION 
  
 There was significant incidence of dyslipoproteinemia in the form of 
elevation of  Incidence of elevated serum  total cholesterol, low density lipoprotein 
cholesterol, Triglycerides and elevation in the incidence of high risk high density 
lipoprotein cholesterol in patients of 40 years and below with acute myocardial 
infarction in the study population, when compared to matched controls. 
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SUMMARY 
 
Seventy cases of proved myocardial infarction in patients with 40 years and 
below were studied. Controls were studied simultaneously. 
The male to female ratio was 68:2 in the study group and all the controls were 
males. 
Age group ranged from 19 years to 40 years of which maximum incidence 
was noticed between 35-40 years. 
12 percent of the study group were smokers, 40 percent were Obese, 11 
percent had hypertension, 17 percent were diabetic mellitus 30 percent had family 
history of CAD. 
Mean Serum cholesterol, TGL, LDLC were elevated in the study group  when 
compared to controls. 
There were 50% incidence of hypercholesterolemia , 35.7% incidence of 
elevated LDLC, 47.14% incidence of elevated  TGL, 40% incidence of high risk 
HDLC in the study group, which all were significant when compared to controls. 
Obesity, diabetes mellitus, hypertension, smokers showed the pattern of 
dyslipoproteinemia in the study group  
Anterior wall MI was seen in 54%, Inferior wall 33%, Posterior wall, 2.85%, 
combined anterior and inferior wall 86% Incidence of   ST elevation MI was 96%. 
Rythymic disturbances was noted in 40% and features of left ventricular failure were 
seen in 25.5%. Mortality was 4% . The incidence of left ventricular systolic 
dysfunction was 35.7%. 
The results were compared with earlier works in the field. Relevant literature were 
reviewed. 
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